Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved garadacimab (brand name Andembry) for patients aged 12 years and older with hereditary angioedema (HAE) to ...

In his March 2023 budget, the then UK Chancellor, Jeremy Hunt, accordingly announced that from 2024 the Medicines and ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jeraygo (aprocitentan) to treat hypertension (high blood pressure) in adults whose blood pressure cannot be adequately ...

and Marketing Authorization granted by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) for the treatment of wet AMD. In the United States, ONS-5010/LYTENAVA ...

As with any medicine, the MHRA will keep the safety and effectiveness of seladelpar under close review.  The Medicines and ...

Pheno Therapeutics has gained clinical trial authorisation (CTA) from the UK's MHRA for its small molecule therapeutic, ...

On January 7, 2024, the U.S. Food and Drug Administration (FDA) published the draft guidance “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing ...

The expansion of digital travel authorisations shows the UK’s commitment to modernising immigration processes. Michelle Holmes from Holmes & Partners Limited explores the associated benefits and risks ...

a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial authorisation ...

announced today it has received clinical trial authorisation (CTA) from the UK's MHRA (Medicines and Healthcare products Regulatory Agency) for its lead candidate, PTD802. A selective GPR17 (G ...